Protagonist Therapeutics, Inc. Share Price

Protagonist Therapeutics, Inc. Share Price

NASDAQ: PTGX | Mid Cap
$144.93
+$0.56 (0.39%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Protagonist Therapeutics, Inc. Stock Performance

Open
$143.86
Prev. Close
$144.37
Circuit Range
N/A
Day Range
$142.83 - $145.44
Year Range
$75.53 - $159.99
Volume
11,750
Average Traded
$144.07

Protagonist Therapeutics, Inc. Share Price Today

As of 31 October 2026, Protagonist Therapeutics, Inc.'s share price is $144.93. The stock opened at $143.86, compared to its previous close of $144.37. During today's trading session, Protagonist Therapeutics, Inc.'s share price traded between $142.83 and $145.44, with an average price of $144.13. Over the past 52 weeks, the stock has recorded a high of $159.99 and a low of $75.53. In terms of performance, Protagonist Therapeutics, Inc.'s share price has risen by 46.50% over the last six months and is up 84.32% on a year-on-year basis.

Protagonist Therapeutics, Inc. Share Price Chart

Line chart of the Protagonist Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 142.56 to 145.46, ending at 144.93.
$142.83$145.44
L
Show Current Price
H

Protagonist Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.21B
PE Ratio (TTM)
112.65
Dividend Yield
0.00%
EPS (TTM)
$1.28
Revenue (TTM)
$46.02B
Return On Equity (TTM)
9.85%
Profit Margin
-282.81%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
513.96%

Protagonist Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$4.71$7.44$56.37$213.48
Net Profit-$39.34-$44.38$3.78$162.85
Net Profit Margin-835.24%-596.51%6.71%76.28%
Income ChangeN/A-12.81%108.52%4208.20%

Protagonist Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$26.58$60.00$434.43$46.02
Net Profit-$127.39-$78.96$275.19-$130.15
Net Profit Margin-479.27%-131.60%63.35%-282.81%
Income ChangeN/A38.02%448.52%-147.29%

About Protagonist Therapeutics, Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Protagonist Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$138.43
$144.85
+2.74%
Sep 2026
$147.60
$140.99
-5.73%
Aug 2026
$135.91
$149.56
+9.32%
Jul 2026
$123.85
$136.81
+11.83%
Jun 2026
$97.85
$122.34
+22.92%
May 2026
$99.13
$99.53
+0.61%
Apr 2026
$106.41
$98.93
-6.26%
Mar 2026
$91.34
$105.54
+14.57%
Feb 2026
$81.56
$92.11
+12.61%
Jan 2026
$86.93
$81.80
-6.29%
Dec 2025
$89.25
$87.30
-2.90%
Nov 2025
$79.14
$89.90
+14.33%

PTGX Share Price FAQs